News
Two experimental therapies from Vicore Pharma and Endeavor BioMedicines that could provide new ways of treating idiopathic pulmonary fibrosis (IPF ... increase in plasma MMP-13 (also known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback